Article

Corneal implants okayed for use in Canada

Addition Technology has received regulatory clearance from Health Canada to market its corneal implants (Intacs) for keratoconus and myopia indications.

Des Plaines, IL-Addition Technology has received regulatory clearance from Health Canada to market its corneal implants (Intacs) for keratoconus and myopia indications.

"Over the past couple of years, there has been considerable interest in [the implants] in Canada," said William M. Flynn, president and chief executive officer of Addition Technology. "We have trained quite a few surgeons to date and expect this procedure to be adopted fairly rapidly within the ophthalmic community."

The implant will be distributed in Canada by I-MED Pharma, which also plans to begin distributing Addition Technology's artificial cornea (AlphaCor) and an orbital implant in development (AlphaSphere) within the next year.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.